中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

HBeAg阴性慢性乙型肝炎研究进展

郑自华 张立伐

引用本文:
Citation:

HBeAg阴性慢性乙型肝炎研究进展

详细信息
  • 中图分类号: R512.62

  • [1]World Health Organization.Hepatitis B[DB].World Health Organi-zation Fact Sheet204. (Revised October2000) .WHO website.ht-tp://www.who.int/mediacentre/factsheets/fs204/en.
    [2]Hadziyannis SJ, Vassilopoulos D.Hepatitis B e antigen-negativechronic hepatitis B[J].Hepatology, 2001, 34 (4) ∶617-624.
    [3]Fattovich G.Natural history of hepatitis B[J].J Hepatol, 2003, 39suppl 1∶S50-S58.
    [4]雷春亮, 彭晓谋, 顾林, 等.HBeAg阴性慢性乙型肝炎患者出现前C区和基本核启动子联合突变的意义[J].中华传染病杂志, 2005, 23 (1) ∶10-13.
    [5]Liaw YF, Leng N, Guan R, et al.Asian-Pacific consensus state-ment on the management of chronic hepatitis B:a 2005 update[J].Liver Int, 2005, 25∶472-489.
    [6]Funk ML, Rosenberg DM, Lok ASF.Word-wide epidemiology ofHBeAg-negative chronic hepatitis B and associated precore and coreprmoter variants[J].J Viral Hepat, 2002, 9∶52-61.
    [7]任红.中国慢性乙型肝炎治疗策略—2004年全国乙型肝炎治疗策略专家峰会纪要[J].中华肝脏病杂志, 2005, 13 (5) ∶326-328.
    [8]Bonino F, Brunetto MR.Chronic hepatitis B e antigen (HBeAg) negative, anti-HBe positive hepatitis B:an overview[J].J Hepatol, 2003, 39 suppl 1∶S160-S163.
    [9] 骆抗先.乙型肝炎基础和临床[M].第2版.北京:人民卫生出版社, 2001∶274.
    [10]Papatheodoridis GV, Hadziyannis SJ.Diagnosis and management ofpre-core mutant chronic hepatitis B[J].J Viral Hepat, 2001, 8, 311-321.
    [11]Anna SF, Lok and Brian J.McMahon.Chronic Hepatitis B:Up-date of Recommendations[J].AASLD PRACTICE GUIDELINE.Hepatology, 2004, 39 (3) ∶857-861.
    [12]de Franchis R, Hadengue A.ESALinternational Consensus Confer-ence on Hepatitis B[J].J Hepatol, 2003, 39 suppl 1∶s3-s25.
    [13]贾继东.乙型肝炎e抗原阴性慢性乙型肝炎的治疗[J].中华肝脏病杂志, 2005, 13 (7) ∶539.
    [14]Lin CC, Wu JC, Chang TT, et al.Long-termevaluation of recom-binant interferon alpha2b in the treatment of patients with hepatitis Be antigen-negative chronic hepatitis B in Taiwan[J].J Viral Hepat, 2001, 8∶438-446.
    [15]Manesis E K, Hadziyannis S J.Interferon alpha treatment and re-treatment of hepatitis B e antigen negative chronic hepatitis B mutants[J].Gastroenterology, 2001, 121∶101-109.
    [16]Marcellin P, Lau GKK, Bonino F, et al.Peginterferon alfa-2a a-lone, lamivudine alone and the two in combination in patients withHBeAg negative chronic hepatitis B[J].NEngl J Med, 2004, 351∶1206-1217.
    [17]Lai CL, Rosmawati M, Lao J, et al.Entecavir is superior to lami-vudine in reducing hepatitis B virus DNA in patients with chronichepatitis B infection[J].Gastroenterology, 2002, 123 (6) ∶1831~1838.
  • 加载中
计量
  • 文章访问数:  1848
  • HTML全文浏览量:  4
  • PDF下载量:  840
  • 被引次数: 0
出版历程
  • 出版日期:  2007-01-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回